Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Classical hematology 2Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Thrombocytopenia 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 90Cyclophosphamide 85Mycophenolic Acid 67Peripheral Blood Stem Cell Transplantation 65Whole-Body Irradiation 59Tacrolimus 58Cyclosporine 46Busulfan 45Antilymphocyte Serum 39fludarabine 35Filgrastim 35Melphalan 33Methotrexate 28Radiotherapy 26Granulocyte Colony-Stimulating Factor 20Sirolimus 17Methylprednisolone 17Etoposide 17Cord Blood Stem Cell Transplantation 17Rituximab 14Stem Cell Transplantation 13Alemtuzumab 13thymoglobulin 11sargramostim 11Cyclosporins 11Therapeutics 10Flow Cytometry 10Cytarabine 10plerixafor 8Thiotepa 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hodgkin Disease × romiplostim × Plasma cell × Clear all
NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
62 enrolled 7 charts
Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT02046291 2021-06-08

Safety of Romiplostim (Nplate®) Following UCBT

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
21 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡